[{"Assets_0_FY_USD":17775795000.0,"EarningsPerShareBasic_4_FY_USD":142.33,"EarningsPerShareBasic_1_FY_USD":-52.59,"EarningsPerShareDiluted_4_FY_USD":140.56,"EarningsPerShareDiluted_1_FY_USD":-52.59,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":656521000.0,"NetIncomeLossConverted_4_FY_USD":4245902000.0,"NetIncomeLossConverted_1_FY_USD":-1573700000.0,"RevenuesConverted_4_FY_USD":2922545000.0,"RevenuesConverted_1_FY_USD":732800000.0,"StockholdersEquity_0_FY_USD":13667134000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":30208000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29831000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20220211"}]